AbbVie (NYSE:ABBV) reported third quarter earnings that beat analyst's expectations on Friday and revenue that topped forecasts.
The firm reported earnings per share of $2.14 on revenue of $8.24B. Analysts polled by expected EPS of $2.01 on revenue of $8.23B. That compared to EPS of $1.41 on revenue of $7.00B in the same period a year earlier. The company had reported EPS of $2 on revenue of $8.26B in the previous quarter.
For the year, AbbVie shares are down 17.06%, under-performing the S&P 500 which is up 2.11% year to date.
AbbVie follows other major Healthcare sector earnings this month
On October 16, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.05B.
Pfizer (NYSE:PFE) earnings beat analyst's expectations on Tuesday, with third quarter EPS of $0.78 on revenue of $13.3B. analysts expected EPS of $0.75 on revenue of $13.55B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
